A detailed history of Caption Management, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 6,300 shares of EOLS stock, worth $68,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,300
Previous 111,900 94.37%
Holding current value
$68,292
Previous $1.21 Million 91.6%
% of portfolio
0.0%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.66 - $17.48 $67,158 - $110,124
6,300 New
6,300 $102,000
Q1 2024

May 15, 2024

BUY
$9.99 - $14.91 $49,950 - $74,550
5,000 New
5,000 $70,000
Q2 2023

Aug 14, 2023

BUY
$7.23 - $10.52 $607,320 - $883,680
84,000 New
84,000 $610,000
Q1 2021

May 17, 2021

SELL
$3.2 - $16.51 $549,964 - $2.84 Million
-171,864 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.92 - $4.84 $457,508 - $758,336
156,681 Added 1031.95%
171,864 $577,000
Q2 2020

Aug 14, 2020

BUY
$3.53 - $6.17 $53,595 - $93,679
15,183 New
15,183 $80,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.